Renal Cancer
Urine cytology in the detection of renal cell carcinomas - a territory-wide multi-institutional retrospective review of more than 2 decades.
February 9, 2024
Gain of Chromosome 5q Predicts a Favorable Prognosis in Localized Renal Cell Carcinoma.
February 8, 2024
Hypermethylated SHOX2 in circulating cell-free DNA post renal cell carcinoma surgery as TNM-independent biomarker for recurrence risk.
February 8, 2024
Interaction between Wnt/β-catenin signaling pathway and EMT pathway mediates the mechanism of sunitinib resistance in renal cell carcinoma.
February 7, 2024
Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.
February 7, 2024
Recurrent MTOR Mutations in Renal Cell Carcinoma With Fibromyomatous Stroma: A Report of 2 Tumors.
February 6, 2024
CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
February 1, 2024
Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data.
February 1, 2024
Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the "TOWARDS" Score.
January 31, 2024
TFE3-splicing factor fusions represent functional drivers and druggable targets in translocation renal cell carcinoma.
January 30, 2024
Urologist-level variation in the management of T1a renal cell carcinoma: A population-based cohort study.
January 29, 2024
The Relationship Between Health-Related Quality of Life and Overall Survival in Patients With Advanced Renal Cell Carcinoma in CheckMate 214.
January 29, 2024